Within A Year, Scientists Claim They Will Have A Complete Cure For Cancer
Some Israeli scientists are telling the world that they will have the first “complete cure” for cancer within a year, The Jerusalem Post reported on Monday, January 28, 2019.
The company, Accelerated Evolution Biotechnologies Ltd. (AEBi), has described its treatment, MuTaTo, as comparable to a cancer antibiotic that uses a multipronged approach similar to the treatment given to HIV patients.
The Israeli team told the news outlet that this treatment relies on a combination of several peptides for each cancer cell, reportedly eliminating the chances of evasion through mutation.
And not only that, but they claim the drug will be brief, cheap and effective and will have no or minimal side-effects.
“We believe we will offer in a year’s time a complete cure for cancer,” Dan Aridor, of AEBi, told the news outlet.
“Our cancer cure will be effective from day one, will last a duration of a few weeks, and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor said, adding that “our solution will be both generic and personal.”
The company’s CEO, Dr. Ilan Morad, said MuTaTo also works to target cancer stem cells, eliminating the chances of recurrence, with Aridor claiming that it will be effective from “Day 1” and cause “no or minimal side effects at a much lower cost than most other treatments.”
“We made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer,” Morad said, adding that “the probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used.”
“Instead of attacking receptors one at a time, we attack receptors three at a time,” he continued. “Not even cancer can mutate three receptors at the same time.”